Zonisamide Attenuates α-Synuclein Neurotoxicity by an Aggregation-Independent Mechanism in a Rat Model of Familial Parkinson’s Disease

• Shigeki Arawaka ,

  * E-mail: arawaka@med.id.yamagata-u.ac.jp

  Affiliation Department of Neurology, Hematology, Metabolism, Endocrinology and Diabetology, Yamagata University Faculty of Medicine, Yamagata, Japan

  ⨯
• Shingo Fukushima,

  Affiliation Department of Neurology, Hematology, Metabolism, Endocrinology and Diabetology, Yamagata University Faculty of Medicine, Yamagata, Japan

  ⨯
• Hiroyasu Sato,

  Affiliation Department of Neurology, Hematology, Metabolism, Endocrinology and Diabetology, Yamagata University Faculty of Medicine, Yamagata, Japan

  ⨯
• Asuka Sasaki,

  Affiliation Department of Neurology, Hematology, Metabolism, Endocrinology and Diabetology, Yamagata University Faculty of Medicine, Yamagata, Japan

  ⨯
• Kaori Koga,

  Affiliation Department of Neurology, Hematology, Metabolism, Endocrinology and Diabetology, Yamagata University Faculty of Medicine, Yamagata, Japan

  ⨯
• Shingo Koyama,

  Affiliation Department of Neurology, Hematology, Metabolism, Endocrinology and Diabetology, Yamagata University Faculty of Medicine, Yamagata, Japan

  ⨯
• Takeo Kato

  Affiliation Department of Neurology, Hematology, Metabolism, Endocrinology and Diabetology, Yamagata University Faculty of Medicine, Yamagata, Japan

  ⨯